OOIR: Observatory of International Research

Papers

(The H4-Index of Neural Regeneration Research is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?	226
Neurogenesis dynamics in the olfactory bulb: deciphering circuitry organization, function, and adaptive plasticity	158
Activation of medial septum cholinergic neurons restores cognitive function in temporal lobe epilepsy	119
Increased retinal venule diameter as a prognostic indicator for recurrent cerebrovascular events: a prospective observational study	105
Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease	95
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target	88
Activity-dependent regulation of cortical cell numbers: Role of neuronal activity in cortical circuit formation	86
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury	80
Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis	74
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics	71
FKBP51: A new target for Parkinson’s disease	70
The intrinsic excitability of and autophagy protein expression levels in dentate gyrus ensembles regulate fear generalization	69
Telomere length as a predictive marker for long-term cognitive function in a mouse model of subarachnoid hemorrhage	69
Intriguing role of the Golgi apparatus in astrocyte function: Implications for disorders	65
Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress	62
Mitochondrial transplantation: a promising strategy for the treatment of retinal degenerative diseases	62
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases	61
Astrocyte chloride, excitatory-inhibitory balance and epilepsy	59
Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease	59
Amyloid-beta and tau protein beyond Alzheimer’s disease	57
Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety	56
Decoding molecular mechanisms: brain aging and Alzheimer’s disease	56
Stepping up after spinal cord injury: negotiating an obstacle during walking	56
Delayed microglial depletion protects against white matter injury following neonatal cerebral hemorrhage in mice	54
Functions of nuclear factor Y in nervous system development, function and health	54

Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders	52
Protocadherin gamma C3: a new player in regulating vascular barrier function	52
Beyond apoptosis: Implications of annexin-V binding to myeloid cells in DARC (Detection of Apoptosing Retinal Cells) imaging	52
Porcine decellularized nerve matrix hydrogel attenuates neuroinflammation after peripheral nerve injury by inhibiting the TLR4/MyD88/NF-κB axis	51
Tropism-shifted AAV-PHP.eB-mediated bFGF gene therapy promotes varied neurorestoration after ischemic stroke in mice	50
Neuromodulation techniques for modulating cognitive function: Enhancing stimulation precision and intervention effects	50
Could inorganic polyphosphate be a valid target against neuronal senescence?	50
Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: Targeting brain metabolic and vascular restoration	48
Glycine decarboxylase as a novel regulator of N-methyl-D-aspartate receptor function: Implications for pathophysiology of schizophrenia	48
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder	48
Potential common pathogenesis of several neurodegenerative diseases	47
Mitochondrial dynamics dysfunction and neurodevelopmental disorders: From pathological mechanisms to clinical translation	47
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy	47
Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease	46
Functional near-infrared spectroscopy in non-invasive neuromodulation	46
Krüppel-like factor 2 (KLF2), a potential target for neuroregeneration	46
Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke	46
Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice	46
The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases	46
Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury	45
The circ_0002538/miR-138-5p/plasmolipin axis regulates Schwann cell migration and myelination in diabetic peripheral neuropathy	45
Ethanol changes Nestin-promoter induced neural stem cells to disturb newborn dendritic spine remodeling in the hippocampus of mice	45
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway	45